Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DXCM
DXCM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DXCM News
Investment Outlook for Healthcare Tech Companies
3d ago
Fool
TransMedics and Dexcom's Market Prospects
3d ago
NASDAQ.COM
Investigation into DexCom Officers' Fiduciary Duties
Apr 09 2026
PRnewswire
DexCom (DXCM) Q2 2025 Earnings Call Transcript
Apr 08 2026
NASDAQ.COM
DexCom Announces Q1 2026 Financial Results Release Plan
Apr 02 2026
Newsfilter
DEXCOM STOCK RISES 0.4% FOLLOWING EVERCORE ISI UPGRADE TO OUTPERFORM FROM IN LINE
Mar 24 2026
moomoo
MIG Capital Reduces Stake in Sotera Health by $37 Million
Mar 15 2026
Yahoo Finance
Adobe CEO Resignation Triggers Stock Decline
Mar 13 2026
CNBC
Dexcom G7 Enhances Diabetes Management and Health Outcomes
Mar 11 2026
Newsfilter
Dexcom CGM Enhances Long-Term Health for Diabetes Patients
Mar 11 2026
Yahoo Finance
Intuitive Surgical and DexCom: Future Prospects Analysis
Mar 10 2026
Fool
Intuitive Surgical and DexCom's Growth Prospects Amid Challenges
Mar 10 2026
NASDAQ.COM
Investigation into DexCom Officers' Fiduciary Duties
Feb 26 2026
PRnewswire
DexCom Positioned to Benefit from GLP-1 Drug Boom
Feb 25 2026
Fool
DexCom Benefits from the Rise of GLP-1 Medications
Feb 25 2026
NASDAQ.COM
DexCom to Present Company Update at 47th Annual Raymond James Conference
Feb 25 2026
Newsfilter
Show More News
